VISACards AcceptedFree Shipping Over $300GTA Third-Party TestedHPLC Purity and Bacterial Endotoxin TestedShips Canada-Wide3+ Vials — 10% Off5+ Vials — 20% Off10+ Vials — 40% OffVISACards AcceptedFree Shipping Over $300GTA Third-Party TestedHPLC Purity and Bacterial Endotoxin TestedShips Canada-Wide3+ Vials — 10% Off5+ Vials — 20% Off10+ Vials — 40% Off
Back to Research Blog
RUO Compliance

RUO Compound Handling, Storage, and Chain-of-Custody Records in Research Laboratories

A reference overview of documentation practices for receiving, storing, and tracking Research Use Only compounds: receipt logs, storage records, lot traceability, and why record-keeping supports reproducible preclinical research.

November 1, 2026
6 min read
ACCUTIDE Research Supply Editorial
This article is for informational and research reference purposes only. It is not legal or regulatory advice. All products sold by ACCUTIDE Research Supply are for research use only (RUO) and are not intended for human or veterinary use. No therapeutic, diagnostic, or preventive claims are made.

Once a Research Use Only (RUO) compound arrives at a laboratory, the documentation trail that began with the supplier's certificate of analysis (COA) needs to continue inside the facility. Chain-of-custody and handling records show which lot was used in which experiment, how it was stored, and who handled it. This article outlines record categories commonly maintained in preclinical research settings.

Why Handling Records Matter for Reproducibility

Analyses of preclinical research have identified incomplete reporting of materials and reagents as a recurring contributor to irreproducible results. Economic analyses of preclinical reproducibility have attributed a substantial share of irreproducibility to biological reagents and reference materials, a category that includes research compounds. Reporting guidelines for animal research likewise call for clear identification of the materials used in each experiment. Handling records give investigators the information needed to meet these expectations.

Receipt and Intake Records

  • Date of receipt, carrier, and tracking reference
  • Condition on arrival, including packaging integrity and any temperature indicators supplied
  • Product name, labelled quantity, and lot number as printed on the vial, checked against the packing slip
  • Lot-specific COA on file, with the lot number matching the vial label
  • Name of the staff member who received and logged the material

Storage Documentation

Lyophilized peptides have been studied extensively for physical and chemical stability, and the literature describes moisture, temperature, and light as factors that influence degradation pathways. Laboratories therefore commonly record the storage location, the labelled storage condition on the supplier's documentation, and any deviations such as freezer excursions. Where a compound is aliquoted, the aliquot date, source lot, and container identifiers are typically recorded so every aliquot can be traced to its parent vial.

Lot Traceability Within Experiments

Recording the lot number in the experimental notebook or electronic laboratory record allows later comparison between experiments run with different lots. If a result cannot be repeated, the lot-specific COA, including HPLC purity and endotoxin data where provided, offers a starting point for evaluating whether material variability may have contributed. A lot number on a COA that does not match the vial in hand is a documentation discrepancy that is generally resolved with the supplier before use.

Access, Use, and Disposal Logs

  • Restricted storage areas with a named responsible investigator
  • Usage logs showing quantity removed, date, and purpose within an approved protocol
  • Disposal records for expired or unused material, following institutional waste procedures
  • Retention of records for the period set by institutional policy

Segregation From Non-Research Material

RUO material is labelled not for human or veterinary use. Facilities commonly keep it physically and procedurally separate from any clinical or consumer-facing stock, with clear labelling so the research-only status remains visible throughout storage and use.

Institutional policies and applicable Canadian regulations determine the specific record-keeping obligations for any facility. Researchers should consult their institution's compliance office for current requirements.
References
  1. 1.Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol. 2015;13(6):e1002165. PMID: 26057340.
  2. 2.Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412. PMID: 20613859.
  3. 3.Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. PMID: 20143256.
  4. 4.Begley CG, Ioannidis JPA. Reproducibility in science: improving the standard for basic and preclinical research. Circ Res. 2015;116(1):116-126. PMID: 25552691.

Related reading

Disclaimer: This article is published by ACCUTIDE Research Supply for informational and research reference purposes only. It does not constitute medical advice, clinical guidance, or any recommendation for human or veterinary use. All referenced compounds are sold by ACCUTIDE Research Supply strictly for Research Use Only (RUO). Consult peer-reviewed literature and your institutional ethics framework before designing any research protocol.
Research updates

Stay ahead of new batches.

New compounds, COA releases, batch testing results, and research content — straight to your inbox.

Research Use Only (RUO): All products are strictly for laboratory research. Not for human or veterinary use. Full disclaimer →